November 26, 2012

When it comes to medication nonadherence, the most oftcited statistic illustrating its effect on the healthcare system is the New England Healthcare Institute's estimate that it costs the healthcare system $290 billion per year. But a new report shows how much drug makers lose as well.

November 26, 2012

Ranbaxy Labs has launched a new treatment for acne under a licensing agreement with a Canadian drug maker.

November 26, 2012

Many health insurance plans are failing to provide coverage mandated by the healthcare reform law for treatments to help smokers and other tobacco users quit, the Campaign for Tobacco-Free Kids reported Monday, citing a study of insurance contracts by Georgetown University researchers that the group commissioned.

November 21, 2012

The Food and Drug Administration on Wednesday announced the approval of Novartis' Flucelvax, the first seasonal influenza vaccine licensed in the United States produced using cultured animal cells, instead of fertilized chicken eggs.

November 20, 2012

Canadian regulators have allowed the approval process for a generic opioid painkiller to go forward despite objections from provincial and other authorities, according to published reports.

November 19, 2012

The American Cancer Society on Friday honored 19 companies, including three retail pharmacy operators and three consumer packaged goods companies, with its Excellence in Philanthropy award — recognizing the companies for their generous support of the society’s efforts to eliminate cancer as a public health burden.

November 19, 2012

The Food and Drug Administration has approved a drug for a condition that can complicate treatment for hepatitis C.

November 19, 2012

The drug-discovery division of the Cystic Fibrosis Foundation is teaming up with drug maker Pfizer to find new treatments for patients with the most common genetic mutation of the disease.

November 19, 2012

Drug maker Shire has started a research program focused on rare diseases and their effects on patients and healthcare professionals, the company said Monday.

November 16, 2012

The Federal Trade Commission has approved a deal by Valeant Pharmaceuticals International to buy a Scottsdale, Ariz.-based drug maker.

November 15, 2012

In the classic Arabian Nights tale “Aladdin and the Magic Lamp,” the sorcerer who sold Aladdin the lamp containing the genie attempts to get it back by walking through the town where Aladdin and his wife live disguised as a merchant, trading “new lamps 
for old.” 


November 15, 2012

The Food and Drug Administration's Nonprescription Drugs Advisory Committee on Friday voted against Merck's application to switch its Oxytrol patch from prescription-only to over the counter, citing concerns over use of therapy for an overactive bladder in women without a doctor's intervention.

November 15, 2012

The Food and Drug Administration has approved a generic drug for leukemia made by a subsidiary of Par Pharmaceutical Cos.


November 15, 2012

Spurred by health reform and other factors, a "golden era" could be approaching for drug companies as they reinvent themselves, according to a new report by PwC.

November 13, 2012

The launch of a tamper-resistant formulation of a popular opioid painkiller in the United States, but not in Canada, may have influenced a spike in dispensing rate of the original at pharmacies in Canadian border cities, according to a study.

November 12, 2012

The Food and Drug Administration has approved a new strength of a drug for HIV made by Johnson & Johnson, the drug maker said.

November 12, 2012

Nearly 80% of office workers polled come to work even when they know they are sick — an increase of 20% over last year — according to the third annual "Flu Season Survey" from Staples.

November 9, 2012

A Food and Drug Administration panel has voted to support two experimental insulin treatments made by Novo Nordisk, the Danish drug maker said Thursday.

November 8, 2012

The Food and Drug Administration has accepted an application from Merck for an experimental drug for insomnia, the drug maker said Thursday.

November 8, 2012

A Food and Drug Administration expert panel has voted unanimously in favor of approval for a Novartis drug for a rare endocrine disorder.

November 8, 2012

GlaxoSmithKline on Thursday announced the five recipients of its annual GlaxoSmithKline IMPACT Awards.

November 7, 2012

A company developing drug-delivery technology based on films inserted into the mouth and a company developing a flu vaccine have entered a deal to combine their products.

November 6, 2012

The Food and Drug Administration has approved a drug for rheumatoid arthritis ahead of the day the agency was scheduled to decide whether or not to approve it, the agency said Tuesday.

November 5, 2012

The Food and Drug Administration has approved a drug made by Johnson & Johnson for treating internal blood clots, the company said.